BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cox CS Jr, Hetz RA, Liao GP, Aertker BM, Ewing-Cobbs L, Juranek J, Savitz SI, Jackson ML, Romanowska-Pawliczek AM, Triolo F, Dash PK, Pedroza C, Lee DA, Worth L, Aisiku IP, Choi HA, Holcomb JB, Kitagawa RS. Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells. Stem Cells 2017;35:1065-79. [PMID: 27800660 DOI: 10.1002/stem.2538] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Bouras M, Asehnoune K, Roquilly A. Immune modulation after traumatic brain injury. Front Med 2022;9. [DOI: 10.3389/fmed.2022.995044] [Reference Citation Analysis]
2 Savitz SI, Cox CS. Cell-based therapies for neurological disorders — the bioreactor hypothesis. Nat Rev Neurol 2022. [DOI: 10.1038/s41582-022-00736-4] [Reference Citation Analysis]
3 Kawabori M, Chida D, Nejadnik B, Stonehouse AH, Okonkwo DO. Cell therapies for acute and chronic traumatic brain injury. Current Medical Research and Opinion 2022. [DOI: 10.1080/03007995.2022.2141482] [Reference Citation Analysis]
4 Su X, Liu Y, Elkashty O, Seuntjens J, Yamada K, Tran S. Human Bone Marrow Cell Extracts Mitigate Radiation Injury to Salivary Gland. J Dent Res. [DOI: 10.1177/00220345221112332] [Reference Citation Analysis]
5 Borlongan MC, Rosi S. Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation. IJMS 2022;23:10286. [DOI: 10.3390/ijms231810286] [Reference Citation Analysis]
6 Goldman L, Siddiqui EM, Khan A, Jahan S, Rehman MU, Mehan S, Sharma R, Budkin S, Kumar SN, Sahu A, Kumar M, Vaibhav K. Understanding Acquired Brain Injury: A Review. Biomedicines 2022;10:2167. [DOI: 10.3390/biomedicines10092167] [Reference Citation Analysis]
7 Huang H, Al Zoubi ZM, Moviglia G, Sharma HS, Sarnowska A, Sanberg PR, Chen L, Xue Q, Siniscalco D, Feng S, Saberi H, Guo X, Xue M, Dimitrijevic MR, Andrews RJ, Mao G, Zhao RC, Han F. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2022). Journal of Neurorestoratology 2022;10:100015. [DOI: 10.1016/j.jnrt.2022.100015] [Reference Citation Analysis]
8 Zhu W, Chen L, Wu Z, Li W, Liu X, Wang Y, Guo M, Ito Y, Wang L, Zhang P, Wang H. Bioorthogonal DOPA-NGF activated tissue engineering microunits for recovery from traumatic brain injury by microenvironment regulation. Acta Biomater 2022:S1742-7061(22)00413-5. [PMID: 35842032 DOI: 10.1016/j.actbio.2022.07.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Oestreich LK, O’sullivan MJ. Transdiagnostic In Vivo Magnetic Resonance Imaging Markers of Neuroinflammation. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2022;7:638-658. [DOI: 10.1016/j.bpsc.2022.01.003] [Reference Citation Analysis]
10 Yang X, Chen L, Pu J, Li Y, Cai J, Chen L, Feng S, He J, Wang Y, Zhang S, Cheng S, Huang H. Guideline of clinical neurorestorative treatment for brain trauma (2022 China version). Journal of Neurorestoratology 2022;10:100005. [DOI: 10.1016/j.jnrt.2022.100005] [Reference Citation Analysis]
11 Cox CS, Juranek J, Kosmach S, Pedroza C, Thakur N, Dempsey A, Rennie K, Scott MC, Jackson M, Kumar A, Aertker B, Caplan H, Triolo F, Savitz SI. Autologous cellular therapy for cerebral palsy: a randomized, crossover trial. Brain Communications 2022;4. [DOI: 10.1093/braincomms/fcac131] [Reference Citation Analysis]
12 Gao C, Nie M, Huang J, Tian Y, Wang D, Zhang J, Jiang R. Pharmacotherapy for mild traumatic brain injury: an overview of the current treatment options. Expert Opin Pharmacother 2022. [PMID: 35290753 DOI: 10.1080/14656566.2022.2054328] [Reference Citation Analysis]
13 Verma N, Fazioli A, Matijasich P. Natural recovery and regeneration of the central nervous system. Regenerative Medicine. [DOI: 10.2217/rme-2021-0084] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Monsour M, Ebedes D, Borlongan CV. A review of the pathology and treatment of TBI and PTSD. Exp Neurol 2022;:114009. [PMID: 35150737 DOI: 10.1016/j.expneurol.2022.114009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Mot YY, Moses EJ, Mohd Yusoff N, Ling KH, Yong YK, Tan JJ. Mesenchymal Stromal Cells-Derived Exosome and the Roles in the Treatment of Traumatic Brain Injury. Cell Mol Neurobiol 2022. [PMID: 35103872 DOI: 10.1007/s10571-022-01201-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cordoba A, Frache B. Treatment of raised intracranial pressure in traumatic head injury. Diagnosis and Treatment of Traumatic Brain Injury 2022. [DOI: 10.1016/b978-0-12-823347-4.00023-3] [Reference Citation Analysis]
17 Köhli P, Otto E, Jahn D, Reisener MJ, Appelt J, Rahmani A, Taheri N, Keller J, Pumberger M, Tsitsilonis S. Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment. Cells 2021;10:2955. [PMID: 34831179 DOI: 10.3390/cells10112955] [Reference Citation Analysis]
18 Cozene B, Sadanandan N, Farooq J, Kingsbury C, Park YJ, Wang ZJ, Moscatello A, Saft M, Cho J, Gonzales-Portillo B, Borlongan CV. Mesenchymal Stem Cell-Induced Anti-Neuroinflammation Against Traumatic Brain Injury. Cell Transplant 2021;30:9636897211035715. [PMID: 34559583 DOI: 10.1177/09636897211035715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
19 Lee DY, Lee SE, Kwon DH, Nithiyanandam S, Lee MH, Hwang JS, Basith S, Ahn JH, Shin TH, Lee G. Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases. Stem Cells Int 2021;2021:8444599. [PMID: 34539792 DOI: 10.1155/2021/8444599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Edlow BL, Sanz LRD, Polizzotto L, Pouratian N, Rolston JD, Snider SB, Thibaut A, Stevens RD, Gosseries O; Curing Coma Campaign and its contributing members. Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions. Neurocrit Care 2021;35:68-85. [PMID: 34236624 DOI: 10.1007/s12028-021-01227-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 16.0] [Reference Citation Analysis]
21 Bonilla C, Zurita M. Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials. Biomedicines 2021;9:669. [PMID: 34200905 DOI: 10.3390/biomedicines9060669] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
22 Ashwal S, Siebold L, Krueger AC, Wilson CG. Post-traumatic Neuroinflammation: Relevance to Pediatrics. Pediatr Neurol 2021;122:50-8. [PMID: 34304972 DOI: 10.1016/j.pediatrneurol.2021.04.010] [Reference Citation Analysis]
23 Öztürk S, Elçin AE, Koca A, Elçin YM. Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives. Stem Cell Rev Rep 2021;17:390-410. [PMID: 32839921 DOI: 10.1007/s12015-020-10029-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
24 Shanko Y, Krivenko S, Goncharov V, Novitskaya V, Zamaro A, Tanin A, Nekhai M, Tokalchik Y, Novikova L, Kolyadich Z, Kulchitsky V. MESENCHYMAL STEM CELLS IN THE COMPLEX TREATMENT OF TRAUMATIC BRAIN INJURY. Med Sci of Ukr 2021;17:11-23. [DOI: 10.32345/2664-4738.1.2021.02] [Reference Citation Analysis]
25 de Fátima Dos Santos Sampaio M, Santana Bastos Boechat M, Augusto Gusman Cunha I, Gonzaga Pereira M, Coimbra NC, Giraldi-Guimarães A. Neurotrophin-3 upregulation associated with intravenous transplantation of bone marrow mononuclear cells induces axonal sprouting and motor functional recovery in the long term after neocortical ischaemia. Brain Res 2021;1758:147292. [PMID: 33516814 DOI: 10.1016/j.brainres.2021.147292] [Reference Citation Analysis]
26 Kawabori M, Weintraub AH, Imai H, Zinkevych L, McAllister P, Steinberg GK, Frishberg BM, Yasuhara T, Chen JW, Cramer SC, Achrol AS, Schwartz NE, Suenaga J, Lu DC, Semeniv I, Nakamura H, Kondziolka D, Chida D, Kaneko T, Karasawa Y, Paadre S, Nejadnik B, Bates D, Stonehouse AH, Richardson RM, Okonkwo DO. Cell Therapy for Chronic TBI: Interim Analysis of the Randomized Controlled STEMTRA Trial. Neurology 2021:10. [PMID: 33397772 DOI: 10.1212/WNL.0000000000011450] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
27 Wei H, Zhou W, Hu G, Shi C. Induction of mesenchymal stem cell‑like transformation in rat primary glial cells using hypoxia, mild hypothermia and growth factors. Mol Med Rep 2021;23:121. [PMID: 33300053 DOI: 10.3892/mmr.2020.11760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Fernandes DC, Reis RL, Oliveira JM. Advances in 3D neural, vascular and neurovascular models for drug testing and regenerative medicine. Drug Discov Today 2021;26:754-68. [PMID: 33202252 DOI: 10.1016/j.drudis.2020.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Lacalle-Aurioles M, Cassel de Camps C, Zorca CE, Beitel LK, Durcan TM. Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury. Front Cell Neurosci 2020;14:594304. [PMID: 33281561 DOI: 10.3389/fncel.2020.594304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
30 Liem NT, Chinh VD, Phuong DTM, Van Doan N, Forsyth NR, Heke M, Thi PAN, Nguyen XH. Outcomes of Bone Marrow-Derived Mononuclear Cell Transplantation for Patients in Persistent Vegetative State After Drowning: Report of Five Cases. Front Pediatr 2020;8:564. [PMID: 33014944 DOI: 10.3389/fped.2020.00564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Nguyen Thanh L, Nguyen HP, Ngo MD, Bui VA, Dam PTM, Bui HTP, Ngo DV, Tran KT, Dang TTT, Duong BD, Nguyen PAT, Forsyth N, Heke M. Outcomes of bone marrow mononuclear cell transplantation combined with interventional education for autism spectrum disorder. Stem Cells Transl Med 2021;10:14-26. [PMID: 32902182 DOI: 10.1002/sctm.20-0102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
32 Willbrand BN, Loh S, O'Connell-Rodwell CE, O'Connell D, Ridgley DM. Phoenix: A Portable, Battery-Powered, and Environmentally Controlled Platform for Long-Distance Transportation of Live-Cell Cultures. Front Bioeng Biotechnol 2020;8:696. [PMID: 32671052 DOI: 10.3389/fbioe.2020.00696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Bonsack B, Corey S, Shear A, Heyck M, Cozene B, Sadanandan N, Zhang H, Gonzales-Portillo B, Sheyner M, Borlongan CV. Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury. CNS Neurosci Ther 2020;26:603-15. [PMID: 32356605 DOI: 10.1111/cns.13378] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
34 Schepici G, Silvestro S, Bramanti P, Mazzon E. Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches. Medicina (Kaunas) 2020;56:E137. [PMID: 32204311 DOI: 10.3390/medicina56030137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
35 Willing AE, Das M, Howell M, Mohapatra SS, Mohapatra S. Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury. CNS Neurosci Ther 2020;26:616-27. [PMID: 32157822 DOI: 10.1111/cns.13300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
36 Xue E, Milano F. Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies. F1000Res 2020;9:F1000 Faculty Rev-26. [PMID: 31984133 DOI: 10.12688/f1000research.20605.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Tan HX, Borgo MPD, Aguilar MI, Forsythe JS, Taylor JM, Crack PJ. The use of bioactive matrices in regenerative therapies for traumatic brain injury. Acta Biomater 2020;102:1-12. [PMID: 31751809 DOI: 10.1016/j.actbio.2019.11.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
38 George MJ, Prabhakara K, Toledano-Furman NE, Gill BS, Wade CE, Cotton BA, Cap AP, Olson SD, Cox CS Jr. Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population. Stem Cells Transl Med 2020;9:491-8. [PMID: 31903737 DOI: 10.1002/sctm.19-0206] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
39 Smith JA, Braga A, Hamel R, Rutigliani C, Yu B, Peruzzotti-jametti L, Pluchino S. The therapeutic potential of exogenous adult stem cells for the injured central nervous system. Handbook of Innovations in Central Nervous System Regenerative Medicine 2020. [DOI: 10.1016/b978-0-12-818084-6.00006-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Bonsack B, Heyck M, Kingsbury C, Cozene B, Sadanandan N, Lee JY, Borlongan CV. Fast-tracking regenerative medicine for traumatic brain injury. Neural Regen Res 2020;15:1179-90. [PMID: 31960797 DOI: 10.4103/1673-5374.270294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
41 Chrostek MR, Fellows EG, Guo WL, Swanson WJ, Crane AT, Cheeran MC, Low WC, Grande AW. Efficacy of Cell-Based Therapies for Traumatic Brain Injuries. Brain Sci 2019;9:E270. [PMID: 31658732 DOI: 10.3390/brainsci9100270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Vahidy FS, Haque ME, Rahbar MH, Zhu H, Rowan P, Aisiku IP, Lee DA, Juneja HS, Alderman S, Barreto AD, Suarez JI, Bambhroliya A, Hasan KM, Kassam MR, Aronowski J, Gee A, Cox CS Jr, Grotta JC, Savitz SI. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial. Stem Cells. 2019;37:1481-1491. [PMID: 31529663 DOI: 10.1002/stem.3080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
43 Ballout N, Rochelle T, Brot S, Bonnet ML, Francheteau M, Prestoz L, Zibara K, Gaillard A. Characterization of Inflammation in Delayed Cortical Transplantation. Front Mol Neurosci 2019;12:160. [PMID: 31293384 DOI: 10.3389/fnmol.2019.00160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
44 Cox CS Jr, Juranek J, Bedi S. Clinical trials in traumatic brain injury: cellular therapy and outcome measures. Transfusion 2019;59:858-68. [PMID: 30737818 DOI: 10.1111/trf.14834] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
45 Shahror RA, Ali AAA, Wu CC, Chiang YH, Chen KY. Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury. Int J Mol Sci 2019;20:E2624. [PMID: 31142002 DOI: 10.3390/ijms20112624] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
46 Jain KK. Neuroprotection in Traumatic Brain Injury. The Handbook of Neuroprotection. New York: Springer; 2019. pp. 281-336. [DOI: 10.1007/978-1-4939-9465-6_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
47 Caplan HW, Cox CS. Resuscitation Strategies for Traumatic Brain Injury. Curr Surg Rep 2019;7:14. [PMID: 31205819 DOI: 10.1007/s40137-019-0237-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
48 Srivastava AK, Prabhakara KS, Kota DJ, Bedi SS, Triolo F, Brown KS, Skiles ML, Brown HL, Cox CS Jr, Olson SD. Human umbilical cord blood cells restore vascular integrity in injured rat brain and modulate inflammation in vitro. Regen Med 2019;14:295-307. [PMID: 31074319 DOI: 10.2217/rme-2018-0106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Li L, Chopp M, Ding G, Davoodi-Bojd E, Li Q, Mahmood A, Xiong Y, Jiang Q. Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging. Brain Res 2019;1717:127-35. [PMID: 31009610 DOI: 10.1016/j.brainres.2019.04.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Lyon A, Mays CE, Borriello F, Telling GC, Soto C, Pritzkow S. Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics. Sci Rep 2019;9:4847. [PMID: 30890734 DOI: 10.1038/s41598-019-41055-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Huang H, Young W, Chen L, Feng S, Zoubi ZMA, Sharma HS, Saberi H, Moviglia GA, He X, Muresanu DF, Sharma A, Otom A, Andrews RJ, Al-Zoubi A, Bryukhovetskiy AS, Chernykh ER, Domańska-Janik K, Jafar E, Johnson WE, Li Y, Li D, Luan Z, Mao G, Shetty AK, Siniscalco D, Skaper S, Sun T, Wang Y, Wiklund L, Xue Q, You SW, Zheng Z, Dimitrijevic MR, Masri WSE, Sanberg PR, Xu Q, Luan G, Chopp M, Cho KS, Zhou XF, Wu P, Liu K, Mobasheri H, Ohtori S, Tanaka H, Han F, Feng Y, Zhang S, Lu Y, Zhang Z, Rao Y, Tang Z, Xi H, Wu L, Shen S, Xue M, Xiang G, Guo X, Yang X, Hao Y, Hu Y, Li J, Ao Q, Wang B, Zhang Z, Lu M, Li T. Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). Cell Transplant 2018;27:310-24. [PMID: 29637817 DOI: 10.1177/0963689717746999] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
52 Tan K, Wang X, Zhang J, Zhuang Z, Dong T. [Effect of chitosan porous scaffolds combined with bone marrow mesenchymal stem cells in repair of neurological deficit after traumatic brain injury in rats]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2018;32:745-52. [PMID: 29905055 DOI: 10.7507/1002-1892.201712047] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
53 Ruppert K, Olson S, Cox C. Spinal Cord Injury. A Roadmap to Non-Hematopoietic Stem Cell-based Therapeutics. Elsevier; 2019. pp. 321-43. [DOI: 10.1016/b978-0-12-811920-4.00013-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Tora MS, Poth KM, Hardcastle N, Sandor K, Anthony C, Di L, Boulis NM. Mechanisms and Clinical Applications of Stem Cell Therapy. Nervous System Drug Delivery 2019. [DOI: 10.1016/b978-0-12-813997-4.00008-6] [Reference Citation Analysis]
55 Wong FS, Tsang KK, Lo AC. Nanoengineered biomaterial for brain tissue reconstruction and functional repairment. Nanoengineered Biomaterials for Regenerative Medicine 2019. [DOI: 10.1016/b978-0-12-813355-2.00007-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Umemura Y, Ogura H, Matsuura H, Ebihara T, Shimizu K, Shimazu T. Bone marrow-derived mononuclear cell therapy can attenuate systemic inflammation in rat heatstroke. Scand J Trauma Resusc Emerg Med 2018;26:97. [PMID: 30445981 DOI: 10.1186/s13049-018-0566-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Zibara K, Ballout N, Mondello S, Karnib N, Ramadan N, Omais S, Nabbouh A, Caliz D, Clavijo A, Hu Z, Ghanem N, Gajavelli S, Kobeissy F. Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury. Neuropharmacology 2019;145:177-98. [PMID: 30267729 DOI: 10.1016/j.neuropharm.2018.09.032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
58 Serrano Sánchez T, González Fraguela ME, Blanco Lezcano L, Alberti Amador E, Caballero Fernández B, Robinson Agramonte MLÁ, Lorigados Pedre L, Bergado Rosado JA. Rotating and Neurochemical Activity of Rats Lesioned with Quinolinic Acid and Transplanted with Bone Marrow Mononuclear Cells. Behav Sci (Basel) 2018;8:E87. [PMID: 30241338 DOI: 10.3390/bs8100087] [Reference Citation Analysis]
59 Nguyen H, Zarriello S, Coats A, Nelson C, Kingsbury C, Gorsky A, Rajani M, Neal EG, Borlongan CV. Stem cell therapy for neurological disorders: A focus on aging. Neurobiol Dis. 2019;126:85-104. [PMID: 30219376 DOI: 10.1016/j.nbd.2018.09.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
60 Neal EG, Liska MG, Lippert T, Lin R, Gonzalez M, Russo E, Xu K, Ji X, Vale FL, Van Loveren H, Borlongan CV. An update on intracerebral stem cell grafts. Expert Rev Neurother 2018;18:557-72. [PMID: 29961357 DOI: 10.1080/14737175.2018.1491309] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
61 Nofianti CE, Sari IN, Marlina, Novialdi, Pawitan JA. Temporary storage solution for adipose derived mesenchymal stem cells. Stem Cell Investig 2018;5:19. [PMID: 30050919 DOI: 10.21037/sci.2018.05.04] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
62 Mays RW, Savitz SI. Intravenous Cellular Therapies for Acute Ischemic Stroke. Stroke 2018;49:1058-65. [DOI: 10.1161/strokeaha.118.018287] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
63 Sun P, Liu DZ, Jickling GC, Sharp FR, Yin KJ. MicroRNA-based therapeutics in central nervous system injuries. J Cereb Blood Flow Metab 2018;38:1125-48. [PMID: 29708005 DOI: 10.1177/0271678X18773871] [Cited by in Crossref: 97] [Cited by in F6Publishing: 107] [Article Influence: 24.3] [Reference Citation Analysis]
64 Piñero G, Usach V, Soto PA, Monje PV, Setton-avruj P. EGFP transgene: a useful tool to track transplanted bone marrow mononuclear cell contribution to peripheral remyelination. Transgenic Res 2018;27:135-53. [DOI: 10.1007/s11248-018-0062-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
65 Wang Y, Pati S, Schreiber M. Cellular therapies and stem cell applications in trauma. Am J Surg 2018;215:963-72. [PMID: 29502858 DOI: 10.1016/j.amjsurg.2018.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
66 Kumar A, Cox CS. Human Umbilical Cord as Treatment for Traumatic Brain Injury in Children. Perinatal Stem Cells 2018. [DOI: 10.1016/b978-0-12-812015-6.00018-2] [Reference Citation Analysis]
67 Le Friec A, Salabert AS, Davoust C, Demain B, Vieu C, Vaysse L, Payoux P, Loubinoux I. Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants. Neural Plast 2017;2017:2545736. [PMID: 29391951 DOI: 10.1155/2017/2545736] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
68 Cox CS Jr. Cellular therapy for traumatic neurological injury. Pediatr Res 2018;83:325-32. [PMID: 28985200 DOI: 10.1038/pr.2017.253] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
69 Reis C, Gospodarev V, Reis H, Wilkinson M, Gaio J, Araujo C, Chen S, Zhang JH. Traumatic Brain Injury and Stem Cell: Pathophysiology and Update on Recent Treatment Modalities. Stem Cells Int 2017;2017:6392592. [PMID: 28852409 DOI: 10.1155/2017/6392592] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
70 Pati S, Rasmussen TE. Cellular therapies in trauma and critical care medicine: Looking towards the future. PLoS Med 2017;14:e1002343. [PMID: 28700606 DOI: 10.1371/journal.pmed.1002343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
71 Jackson ML, Srivastava AK, Cox CS Jr. Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis. J Surg Res 2017;214:38-48. [PMID: 28624058 DOI: 10.1016/j.jss.2017.02.078] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
72 Diaz MF, Vaidya AB, Evans SM, Lee HJ, Aertker BM, Alexander AJ, Price KM, Ozuna JA, Liao GP, Aroom KR, Xue H, Gu L, Omichi R, Bedi S, Olson SD, Cox CS Jr, Wenzel PL. Biomechanical Forces Promote Immune Regulatory Function of Bone Marrow Mesenchymal Stromal Cells. Stem Cells 2017;35:1259-72. [PMID: 28181347 DOI: 10.1002/stem.2587] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
73 Gurcan C, Taheri H, Yilmazer A. Introduction to In Vivo Cell Reprogramming Technology. In Vivo Reprogramming in Regenerative Medicine 2017. [DOI: 10.1007/978-3-319-65720-2_1] [Reference Citation Analysis]
74 Weiss J, Levy S. Neurologic Stem Cell Treatment Study (NEST) using bone marrow derived stem cells for the treatment of neurological disorders and injuries: study protocol for a nonrandomized efficacy trial. Clin Trials Degener Dis 2016;1:176. [DOI: 10.4103/2468-5658.196984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]